These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15113884)
21. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor. Cho WK; Seong YR; Lee YH; Kim MJ; Hwang KS; Yoo J; Choi S; Jung CR; Im DS Mol Ther; 2004 Nov; 10(5):938-49. PubMed ID: 15509511 [TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of the leaky expression of adenovirus genes in cells transduced with a replication-incompetent adenovirus vector. Shimizu K; Sakurai F; Machitani M; Katayama K; Mizuguchi H Mol Pharm; 2011 Aug; 8(4):1430-5. PubMed ID: 21682288 [TBL] [Abstract][Full Text] [Related]
23. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters. Hoffmann D; Jogler C; Wildner O J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123 [TBL] [Abstract][Full Text] [Related]
24. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy. Li W; Tan J; Wang P; Li N; Li C Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753 [TBL] [Abstract][Full Text] [Related]
25. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429 [TBL] [Abstract][Full Text] [Related]
26. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication. Hernandez-Alcoceba R; Pihalja M; Qian D; Clarke MF Hum Gene Ther; 2002 Sep; 13(14):1737-50. PubMed ID: 12396626 [TBL] [Abstract][Full Text] [Related]
27. Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1. Frost JR; Mendez M; Soriano AM; Crisostomo L; Olanubi O; Radko S; Pelka P J Virol; 2018 Jul; 92(14):. PubMed ID: 29743362 [TBL] [Abstract][Full Text] [Related]
28. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity. Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462 [TBL] [Abstract][Full Text] [Related]
29. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells. Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141 [TBL] [Abstract][Full Text] [Related]
30. Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells. Rivera AA; Davydova J; Schierer S; Wang M; Krasnykh V; Yamamoto M; Curiel DT; Nettelbeck DM Gene Ther; 2004 Dec; 11(23):1694-702. PubMed ID: 15496964 [TBL] [Abstract][Full Text] [Related]
31. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus. Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900 [TBL] [Abstract][Full Text] [Related]
32. Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors. Howe JA; Pelka P; Antelman D; Wilson C; Cornell D; Hancock W; Ramachandra M; Avanzini J; Horn M; Wills K; Sutjipto S; Ralston R Virology; 2006 Feb; 345(1):220-30. PubMed ID: 16246392 [TBL] [Abstract][Full Text] [Related]
33. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. Caravokyri C; Leppard KN J Virol; 1995 Nov; 69(11):6627-33. PubMed ID: 7474071 [TBL] [Abstract][Full Text] [Related]
34. Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX. Vellinga J; Rabelink MJ; Cramer SJ; van den Wollenberg DJ; Van der Meulen H; Leppard KN; Fallaux FJ; Hoeben RC J Virol; 2004 Apr; 78(7):3470-9. PubMed ID: 15016870 [TBL] [Abstract][Full Text] [Related]
35. Control of adenovirus early gene expression during the late phase of infection. Fessler SP; Young CS J Virol; 1998 May; 72(5):4049-56. PubMed ID: 9557693 [TBL] [Abstract][Full Text] [Related]
36. [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes]. Shimizu K; Sakurai F; Tachibana M; Mizuguchi H Yakugaku Zasshi; 2012; 132(12):1407-12. PubMed ID: 23208048 [TBL] [Abstract][Full Text] [Related]
37. Differential effect of DNA supercoiling on transcription of adenovirus genes in vitro. Banerjee S; Spector DJ J Gen Virol; 1992 Oct; 73 ( Pt 10)():2631-8. PubMed ID: 1402805 [TBL] [Abstract][Full Text] [Related]
38. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity. Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958 [TBL] [Abstract][Full Text] [Related]
39. Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses. Zhu M; Bristol JA; Xie Y; Mina M; Ji H; Forry-Schaudies S; Ennist DL J Virol; 2005 May; 79(9):5455-65. PubMed ID: 15827160 [TBL] [Abstract][Full Text] [Related]
40. A cis-acting element 7 bp upstream of the ESF-1-binding motif is involved in E1A 13S autoregulation of the adenovirus 12 TS2 promoter. PĆ¼tzer BM; Gnauck J; Kirch HC; Brockmann D; Esche H J Gen Virol; 1997 Apr; 78 ( Pt 4)():879-91. PubMed ID: 9129662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]